JD Health International stock

6618 · HKEX · HKD

Compare JD Health International
$32.60Change from previous close: +0.56%Absolute change: +$0.18

Close · November 20, 2026

Price history

−52.06% over the period

1 year: from $68.00 (November 20, 2025) to $32.60 (November 20, 2026), −52.06%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$32.60
October 30, 2026$38.10
September 30, 2026$36.00
August 31, 2026$36.50
July 31, 2026$39.40
June 30, 2026$32.84
May 29, 2026$38.40
April 30, 2026$45.36
March 31, 2026$47.06
February 27, 2026$56.75
January 30, 2026$63.25
December 31, 2025$55.55
November 28, 2025$61.10
November 20, 2025$68.00

At a glance

  • The company

    Operates an online healthcare platform in China offering medical consultations, health check-ups, home care services, medical devices and pharmaceutical products

  • Latest results

    Quarter to June 30, 2026 · EPS ¥1.07

TickerLandia's take on JD Health International

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$31.84
52-wk high$71.70

−54.53% from the 52-week high

Analysts · 17 analysts

Average target$64.11+96.65% vs. price

Buy 16 · Hold 1 · Sell 0 · Strong buy

TickerLandia Fingerprint: JD Health International

Compared with similar companies: very high financial strength.

Financials and price compared with 130 companies in related industries (retail), worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

JD Health International is cheaper than similar companies

JD Health International's P/E (trailing 12 months): 15.0, −34% against the median of a group of 10 similar companies (22.8).

Compared with 10 similar companies

JD Health International's metrics compared with similar companies
MetricJD Health InternationalPosition in the groupBand
P/E (trailing 12 months)15.0Low
Forward P/E11.3Low
Operating margin6.1%Middle
ROE10.4%Low
Debt/equity0.01Low

Grey band: the middle half of the group; tick: the median; dot: JD Health International. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥40.89B

Latest quarter · Q2 2026

Net income

¥3.44B

Latest quarter · Q2 2026

Quarterly net margin

8.4%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$103.98B
P/E
15.0
EPS
$2.17
Volume
18.52M
Daily trading
€59.44M
Dividend yield
0.00%

How JD Health International is changing

All results
  • Revenue grew 30.5% a year on average over the last 5 years

  • Operating margin rose from −0.3% to 5.2%

  • Profits turn into cash: free cash flow equal to 161% of net income

Returns

JD Health International returns

$1,000 invested in JD Health International 5 years ago, on November 22, 2021, would be worth $464 today: −53.59% in total, −14.25% per year. This is the price return only: dividends are excluded.

PeriodJD Health InternationalHang Seng$1,000 becomes
1 month−18.09%−6.10%$819
6 months−19.27%−12.63%$807
Year to date−41.31%−12.56%$587
1 year−52.06%−13.26%$479
3 years−18.30%+26.06%$817
5 years−53.59%−10.18%$464

Over the last 6 months it has done better than 25% of the stocks in the Consumer sector.

Price only, without dividends. Calculate your investment

The chart in detail

JD Health International: technical analysis

JD Health International is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 83.3% below its all-time closing high ($195.00, December 23, 2020).

Trend
Downward
RSI (14 sessions)
30
Below 30: a strong fall in a short time
vs 200-session average
−23.08%

Active signals

  • RSI below 30: the stock has fallen a lot in a short time.

    since November 19, 2026

Support and resistance

Price areas where JD Health International has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$37.45+14.89%3 touches, last on September 29, 2026
  2. Resistance$35.50+8.88%4 touches, last on October 29, 2026
  3. Resistance$33.44+2.58%2 touches, last on October 2, 2026
  4. Last price$32.60
  5. No support below: the price is near the lows of the year

Volatility and risk

Over the last year it has moved more than the Hang Seng.

Beta (1 year) vs Hang Seng
1.50
Volatility (60 sessions, annualised)
49.9%
Largest fall in the last year
−54.08%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

JD Health International: seasonality

Average monthly price change over 6 years

−2.2%Jan−3.0%Feb−9.6%Mar+2.7%Apr−6.8%May+1.2%Jun+4.1%Jul−3.4%Aug+5.9%Sep−8.1%Oct+12.9%Nov−1.8%Dec

Over the last 6 years, the strongest month for JD Health International has been November: +12.86% on average, positive in 4 years out of 5. The weakest has been March: −9.61% on average, positive in 1 years out of 6.

Show chart data
MonthAverageMedianPositive years
January−2.24%+1.65%4 of 6
February−2.97%−7.11%2 of 6
March−9.61%−11.99%1 of 6
April+2.71%+1.55%3 of 6
May−6.81%−8.95%1 of 6
June+1.22%+4.79%4 of 6
July+4.13%+8.10%4 of 6
August−3.44%−7.76%2 of 6
September+5.92%+1.25%3 of 6
October−8.12%−8.49%1 of 6
November+12.86%+1.98%4 of 5
December−1.76%−0.35%2 of 5

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

JD Health International and its competitors

JD Health International Inc. builds its activities around internet healthcare in China, combining online medical consultation, hospital and doctor referrals, health check-ups and genetic testing with home care such as wound care, blood tests and post-operative care. Its device range includes smart monitoring and respiratory therapy equipment, blood glucose meters, oxygen generators and rapid testing products. Pharmaceutical and healthcare goods reach consumers through direct sales, an online marketplace and on-demand retail, while advertisers and pharmaceutical and healthcare product companies form the other groups of customers.

Headquarters
Beijing, China
Employees
6,018
Founded
2014
Chief executive
Cao Dong
JD Health International and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
JD Health International6618$13.26B6.1%15.0−19.27%
Alibaba Health Information Tech0241$5.4B5.3%20.1−33.12%
Raia DrogasilRADL3$4.04B6.1%17.6−24.57%
Redcare PharmacyRDC$1.47B0.3%—+36.52%
SHEIN Global Holdings0625$15.42B2.7%7.10—
Taiwan Mobile3045$11.4B11.6%22.7+6.96%

Same industry or related industries, similar size. Compare JD Health International with its competitors · Full profile